Description
Rasna Churna
Patanjali Divya Rasna Churna is an ayurvedic medicine that is primarily used for the treatment of Arthritis, Gout. The properties of which have been shared below. The correct dosage of Churna depends on the patient’s age, gender, and medical history.
Divya Rasna Churna contains Rasna (Pluchea lacneolata) as the main ingredient.
– A natural cure for all problems of the nervous system, especially of the nerves
– A natural cure for all problems of the nervous system, especially of the nerves
Read More: Divya Rasna Churna
Key benefits/uses:
– Helps in the conditions like neuritis, sciatica, and chronic inflammation of the nervous system.
– Used to treat Rheumatoid arthritis and Vata disorders
– Useful in health problems related to the female Genital system like Amenorrhoea, dysmenorrhoea.
– Acts as an antipyretic
– Useful in skin diseases like itching, and eczema
– Specific action for delay sign of aging
– Used to treat Rheumatoid arthritis and Vata disorders
– Useful in health problems related to the female Genital system like Amenorrhoea, dysmenorrhoea.
– Acts as an antipyretic
– Useful in skin diseases like itching, and eczema
– Specific action for delay sign of aging
Direction for use/Dosage:
– Take Divya Rasna Churna as directed by the physician
Indications:
– Diseases of a nervous system, joints, alleviate dryness, aging
Storage instructions:
– Store the formulation in cool and dry place
Safety information:
– Read the label carefully before use
– Do not exceed the recommended dose
– Keep out of the reach and sight of children
– Do not exceed the recommended dose
– Keep out of the reach and sight of children
Other Product Info
Best before-24 months from manufacturing date.
Side Effects
No side effects of Churna have been reported in the medical literature. However, you should always consult your doctor before using Churna.
How to Take Churna
You can take Churna with following:
- Can I take Churna with LukeWarm Water?
There is no harm in having lukewarm water with Churna.
There are no reviews yet.